GO:0106302 arachidonate 8,9-epoxygenase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0106302 defines arachidonate 8,9-epoxygenase activity, an NADPH- and oxygen-dependent catalytic activity that converts arachidonic acid to cis-8,9-epoxyeicosatrienoic acid.
• This activity belongs to the cytochrome P450 epoxygenase branch of arachidonic acid metabolism, which generates epoxyeicosatrienoic acids (EETs) with roles in vascular, renal, and inflammatory biology.
• The reaction requires molecular oxygen and reducing equivalents from NADPH, typically supplied by the cytochrome P450 oxidoreductase (POR) system.
• Arachidonate 8,9-epoxygenase activity is distinct from lipoxygenase and cyclooxygenase pathways, although some enzymes may show overlapping substrate specificity.
• Dysregulation of arachidonic acid epoxygenation has been linked to cardiovascular, renal, and inflammatory conditions, making it a target for functional studies.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal interrogation of genes encoding or regulating this activity.
Description
Arachidonate 8,9-epoxygenase activity (GO:0106302) is a molecular function that catalyzes the NADPH- and oxygen-dependent conversion of arachidonic acid to cis-8,9-epoxyeicosatrienoic acid. This activity is part of the cytochrome P450 epoxygenase pathway, which produces epoxyeicosatrienoic acids (EETs) that act as lipid signaling molecules in diverse physiological contexts. Understanding this specific epoxygenation step is important because it represents a point of divergence from other arachidonic acid metabolic routes, such as lipoxygenase- and cyclooxygenase-mediated pathways. Researchers study GO:0106302 to dissect how individual cytochrome P450 enzymes contribute to the broader pool of EETs and to identify selective regulators of 8,9-EET production. The activity is defined by its regio- and stereospecificity, generating the cis-8,9-epoxide, which distinguishes it from other epoxygenase activities that produce different EET regioisomers. Because EETs influence vascular tone, inflammation, and cellular stress responses, precise functional annotation of GO:0106302 supports mechanistic studies in cardiovascular and metabolic research. Experimental approaches to study this activity include heterologous expression of candidate enzymes, lipidomics, and genetic perturbation using CRISPR-based models.
arachidonate 8,9-epoxygenase activity At A Glance
| GO ID | GO:0106302 |
|---|---|
| GO term | arachidonate 8,9-epoxygenase activity |
| Ontology | molecular_function |
| Synonym | arachidonic acid 8,9-epoxygenase activity |
| Definition | Catalysis of an NADPH- and oxygen-dependent reaction that converts arachidonic acid to cis-8,9-epoxyeicosatrienoic acid. |
| Major function | Epoxygenation of arachidonic acid at the 8,9-double bond to generate cis-8,9-EET. |
| Cofactors | NADPH and molecular oxygen. |
| Pathway context | Cytochrome P450 epoxygenase branch of arachidonic acid metabolism. |
| Product | cis-8,9-epoxyeicosatrienoic acid (8,9-EET). |
What Is GO:0106302?
In simple terms, GO:0106302 describes an enzyme activity that uses oxygen and NADPH to add an epoxide group across the 8,9-double bond of arachidonic acid, producing cis-8,9-epoxyeicosatrienoic acid. This is a cytochrome P450-type epoxygenation reaction, and it is one of several possible epoxygenation events that can occur on arachidonic acid. The term is defined by its substrate (arachidonic acid), its product (cis-8,9-EET), and its cofactor requirements (NADPH and molecular oxygen). It does not describe a specific gene product but rather a catalytic capability that may be associated with one or more cytochrome P450 enzymes.
Why Is arachidonate 8,9-epoxygenase activity Important in Cell Biology?
GO:0106302 is important because it defines a specific enzymatic step in the cytochrome P450 epoxygenase pathway that generates bioactive lipid mediators from arachidonic acid. The product, cis-8,9-EET, belongs to the EET family, which has been implicated in the regulation of vascular tone, renal function, and inflammatory responses. By annotating this activity precisely, researchers can distinguish it from other epoxygenation events and from lipoxygenase- or cyclooxygenase-mediated arachidonic acid metabolism. This precision is essential for interpreting genetic and pharmacological studies that aim to modulate EET levels in disease models.
• Provides a defined biochemical activity for annotating cytochrome P450 enzymes with 8,9-epoxygenase specificity.
• Links arachidonic acid metabolism to the production of cis-8,9-EET, a signaling lipid with vascular and renal effects.
• Helps differentiate epoxygenase activity from lipoxygenase and cyclooxygenase pathways that also act on arachidonic acid.
• Supports mechanistic studies of cardiovascular and inflammatory diseases where EETs are implicated.
• Enables functional comparison of different cytochrome P450 isoforms that may exhibit overlapping substrate specificity.
• Facilitates the design of CRISPR knockout or knock-in models to test the contribution of candidate genes to 8,9-EET production.
• Aids in the interpretation of lipidomic data by providing a clear enzymatic definition for 8,9-EET synthesis.
• Provides a foundation for structure-function studies of cytochrome P450 enzymes that catalyze 8,9-epoxygenation.
What Happens During arachidonate 8,9-epoxygenase activity?
Substrate binding and oxygen activation
In simple terms: The enzyme first grabs arachidonic acid and activates oxygen so it can be inserted into the fatty acid.
The reaction begins with the binding of arachidonic acid to the active site of a cytochrome P450 enzyme. Molecular oxygen is then activated at the heme iron center, a step that requires reducing equivalents typically provided by NADPH via cytochrome P450 oxidoreductase. This activation prepares the oxygen for insertion into the substrate.
Regiospecific epoxidation at the 8,9-double bond
In simple terms: Oxygen is added specifically across the 8,9-double bond of arachidonic acid, forming an epoxide ring.
The activated oxygen species is inserted across the 8,9-double bond of arachidonic acid, generating cis-8,9-epoxyeicosatrienoic acid. This step is regio- and stereospecific, distinguishing it from epoxygenation at other double bonds that would yield different EET regioisomers. The reaction consumes NADPH and molecular oxygen.
Product release and downstream signaling
In simple terms: The newly made 8,9-EET is released and can act as a signaling molecule in the cell.
After formation, cis-8,9-EET is released from the enzyme and can participate in autocrine or paracrine signaling. EETs are known to influence vascular tone, inflammation, and cellular stress responses. The fate of 8,9-EET includes further metabolism by soluble epoxide hydrolase or incorporation into membrane lipids.
Cofactor regeneration and catalytic cycle
In simple terms: The enzyme needs a continuous supply of NADPH to keep working.
Continued catalysis requires regeneration of NADPH, which is maintained by cellular metabolic pathways. The cytochrome P450 oxidoreductase transfers electrons from NADPH to the P450 heme center, completing the catalytic cycle. Disruption of this electron transfer chain reduces 8,9-epoxygenase activity.
Key Genes Involved in GO:0106302 arachidonate 8,9-epoxygenase activity
The following genes and proteins are relevant to arachidonate 8,9-epoxygenase activity, either as candidate enzymes, electron transfer partners, or downstream metabolic regulators.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CYP2C8 | Cytochrome P450 enzyme capable of epoxygenating arachidonic acid | Candidate for 8,9-epoxygenase activity; target for knockout and overexpression studies |
| CYP2C9 | Cytochrome P450 enzyme with epoxygenase activity | May contribute to EET production; studied via point mutations |
| CYP2J2 | Major arachidonic acid epoxygenase in cardiovascular tissues | Frequently investigated for EET-mediated effects; knockout models available |
| CYP2C19 | Cytochrome P450 enzyme with epoxygenase activity | Potential contributor to 8,9-EET formation; pharmacogenetic relevance |
| POR | Cytochrome P450 oxidoreductase, transfers electrons from NADPH | Essential for all P450 epoxygenase activities; knockout is lethal |
| EPHX2 | Soluble epoxide hydrolase, degrades EETs | Regulates 8,9-EET levels; target for inhibitor studies |
| PLA2G4A | Phospholipase A2, releases arachidonic acid from membranes | Upstream regulator of substrate availability |
| PTGS1 | Cyclooxygenase 1, competing pathway for arachidonic acid | Context for pathway crosstalk |
| PTGS2 | Cyclooxygenase 2, competing pathway for arachidonic acid | Inflammation-linked competitor of epoxygenation |
| ALOX5 | Lipoxygenase, competing pathway for arachidonic acid | May influence substrate availability |
| ALOX12 | Lipoxygenase, competing pathway | Context for arachidonic acid metabolism |
| ALOX15 | Lipoxygenase, competing pathway | Context for arachidonic acid metabolism |
| CYP4A11 | Omega-hydroxylase, alternative arachidonic acid metabolism | May compete for substrate |
| CYP4F2 | Omega-hydroxylase, alternative pathway | Potential crosstalk with epoxygenases |
| NCOA4 | Ferritinophagy regulator, linked to lipid peroxidation | Indirect relevance to lipid signaling |
| GPX4 | Glutathione peroxidase, protects against lipid peroxidation | Modulates oxidative stress that can affect lipid mediators |
| NFE2L2 | Nrf2, regulates antioxidant response | May influence oxidative environment for epoxygenases |
| P2RX7 | P2X receptor, lipid-sensitive inflammation modulator | Links lipid signaling to inflammation |
How Is arachidonate 8,9-epoxygenase activity Regulated?
Arachidonate 8,9-epoxygenase activity is regulated at multiple levels. Substrate availability is controlled by phospholipase A2 enzymes that release arachidonic acid from membrane phospholipids. The expression and activity of cytochrome P450 epoxygenases can be influenced by transcriptional and post-transcriptional mechanisms, although specific regulators of 8,9-epoxygenase activity are not fully defined. Cofactor supply, particularly NADPH, and the electron transfer efficiency of cytochrome P450 oxidoreductase are critical determinants of catalytic rate. Additionally, the product 8,9-EET can be degraded by soluble epoxide hydrolase (EPHX2), which effectively regulates its steady-state levels. Oxidative stress and lipid peroxidation pathways may also impact the availability of arachidonic acid and the redox state of the enzyme.
arachidonate 8,9-epoxygenase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CYP2J2 | Cardiovascular and renal function | Knockout and overexpression models in endothelial cells |
| EPHX2 | Hypertension and inflammation | Knockout or inhibitor-treated models |
| PLA2G4A | Inflammatory diseases | Knockout to reduce substrate availability |
| GPX4 | Ferroptosis and oxidative stress | Knockout or point mutation to assess lipid peroxidation |
| P2RX7 | Inflammation and pain | Knockout to study lipid-receptor crosstalk |
Cardiovascular and renal function
EETs, including 8,9-EET, have been implicated in the regulation of vascular tone and renal function. Alterations in epoxygenase activity could affect blood pressure and kidney homeostasis, making GO:0106302 relevant to cardiovascular and renal research. However, direct evidence linking the specific 8,9-epoxygenase activity to human disease remains an active area of investigation.
Inflammation and pain
Arachidonic acid metabolites are central to inflammatory signaling. The epoxygenase pathway can produce anti-inflammatory or pro-resolving mediators in some contexts, while other pathways like lipoxygenase and cyclooxygenase generate pro-inflammatory eicosanoids. The balance between these pathways may influence inflammatory diseases.
Metabolic and oxidative stress
Lipid peroxidation and oxidative stress can impact arachidonic acid metabolism. The Nrf2/GPX4 axis, which protects against ferroptosis, may modulate the oxidative environment that affects epoxygenase activity. This suggests a potential link between GO:0106302 and cellular stress responses, though direct evidence is limited.
From arachidonate 8,9-epoxygenase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene encode 8,9-epoxygenase activity? | Overexpression in HEK293 or COS-7 cells followed by lipidomics |
| Is the activity required for a physiological response? | CRISPR knockout in relevant cell type (e.g., endothelial cells) |
| Does a specific residue determine regiospecificity? | Point mutation at active site residues followed by activity assay |
| Can a tag be used to track the enzyme? | Knock-in of FLAG or GFP tag at the endogenous locus |
| Does increasing activity alter disease phenotype? | Overexpression in animal models or organoids |
| What is the role of the electron transfer partner? | Knockout or knockdown of POR |
How to Study the arachidonate 8,9-epoxygenase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS lipidomics | Levels of cis-8,9-EET and other oxylipins | Quantifying product formation in cells or tissues |
| Recombinant enzyme assay | Catalytic activity and kinetics | Testing candidate enzymes for 8,9-epoxygenase activity |
| CRISPR knockout | Loss-of-function effects on EET production | Validating gene function in cell models |
| CRISPR point mutation | Effect of specific amino acid changes | Mapping active site residues |
| CRISPR knock-in tag | Protein localization and interactions | Tracking endogenous enzyme |
| Overexpression | Gain-of-function effects | Testing sufficiency of a candidate gene |
| RNA-seq | Gene expression profiles | Identifying candidate epoxygenases |
| Proteomics | Protein abundance and modifications | Confirming enzyme expression |
Lipidomics and mass spectrometry
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) can quantify cis-8,9-EET and other arachidonic acid metabolites in biological samples. This method is essential for confirming that a candidate enzyme produces the specific 8,9-epoxide. Stable isotope-labeled internal standards improve quantification accuracy.
Enzyme activity assays
In vitro assays using recombinant cytochrome P450 enzymes and arachidonic acid can directly measure 8,9-epoxygenase activity. NADPH consumption or product formation can be monitored spectrophotometrically or by mass spectrometry. These assays help determine kinetic parameters and cofactor requirements.
Genetic perturbation with CRISPR
CRISPR-Cas9 knockout of candidate genes in cell lines or primary cells allows assessment of their contribution to 8,9-EET production. Point mutations can be introduced to test specific residues, while knock-in of tags enables localization studies. Overexpression models can test gain-of-function effects.
Expression profiling and bioinformatics
RNA-seq and proteomics can identify which cytochrome P450 enzymes are expressed in a given tissue or cell type. Bioinformatics analysis of gene expression datasets can reveal correlations between candidate genes and EET levels. These approaches prioritize genes for functional validation.
How CRISPR Can Be Used to Study GO:0106302 arachidonate 8,9-epoxygenase activity
Knockout
CRISPR knockout of candidate cytochrome P450 genes can abolish or reduce 8,9-epoxygenase activity, allowing researchers to test necessity. Knockout cell lines can be generated in relevant cell types, such as endothelial or hepatic cells, and then analyzed by lipidomics. This approach is particularly useful for distinguishing between redundant enzymes.
Point Mutation
Point mutations can be introduced into the active site of candidate enzymes to test the role of specific residues in substrate binding or catalysis. For example, mutating the heme-coordinating cysteine or substrate-contacting residues can alter regiospecificity. These models help link structure to function.
Knock-in
Knock-in of epitope tags (e.g., FLAG, HA) or fluorescent proteins (e.g., GFP) at the endogenous locus enables tracking of the enzyme without overexpression artifacts. Tagged knock-in models can be used for immunoprecipitation, imaging, or proximity labeling. This approach preserves native regulation.
Overexpression
Overexpression of a candidate gene in a heterologous system (e.g., HEK293 cells) can test whether it is sufficient to produce 8,9-EET. This is often the first step in characterizing a new epoxygenase. Overexpression models can also be used to study downstream effects of increased 8,9-EET.
How EDITGENE Supports arachidonate 8,9-epoxygenase activity Research
Researchers studying arachidonate 8,9-epoxygenase activity-related genes often need to determine whether a candidate gene is causally involved in the production of cis-8,9-EET or in downstream biological responses. This requires precise genetic models that can knock out, mutate, tag, or overexpress the gene of interest in relevant cell types. EDITGENE provides a comprehensive suite of CRISPR-based services to support such functional studies.
Contact EDITGENE today to design your custom CRISPR model for arachidonate 8,9-epoxygenase activity research.
Frequently Asked Questions About arachidonate 8,9-epoxygenase activity
What is arachidonate 8,9-epoxygenase activity?
It is an NADPH- and oxygen-dependent enzymatic activity that converts arachidonic acid to cis-8,9-epoxyeicosatrienoic acid, defined by GO:0106302.
What genes are involved in arachidonate 8,9-epoxygenase activity?
Cytochrome P450 genes such as CYP2C8, CYP2C9, CYP2J2, and CYP2C19 are candidates, along with the electron transfer partner POR.
What is the product of arachidonate 8,9-epoxygenase activity?
The product is cis-8,9-epoxyeicosatrienoic acid, also known as 8,9-EET.
What cofactors are required for arachidonate 8,9-epoxygenase activity?
The reaction requires NADPH and molecular oxygen.
How is arachidonate 8,9-epoxygenase activity different from other epoxygenase activities?
It specifically epoxidizes the 8,9-double bond of arachidonic acid, producing the 8,9-EET regioisomer, whereas other epoxygenases may target different double bonds.
What diseases are associated with arachidonate 8,9-epoxygenase activity?
EETs have been implicated in cardiovascular, renal, and inflammatory conditions, though direct links to the specific 8,9-epoxygenase activity require further study.
How can I study arachidonate 8,9-epoxygenase activity in the lab?
Common methods include LC-MS/MS lipidomics, recombinant enzyme assays, and CRISPR-based genetic perturbation.
What CRISPR models are available for studying this activity?
Knockout, point mutation, knock-in, and overexpression models can be generated for candidate genes.
Is there a specific inhibitor for arachidonate 8,9-epoxygenase activity?
No selective inhibitor is widely established; however, general cytochrome P450 inhibitors or soluble epoxide hydrolase inhibitors can modulate EET levels.
Where can I find the official definition of GO:0106302?
The official definition is available in QuickGO, stating catalysis of an NADPH- and oxygen-dependent reaction that converts arachidonic acid to cis-8,9-epoxyeicosatrienoic acid.
Conclusion
GO:0106302 arachidonate 8,9-epoxygenase activity defines a specific cytochrome P450-mediated epoxygenation step in arachidonic acid metabolism, producing cis-8,9-EET. Understanding this activity is important for dissecting lipid signaling in cardiovascular, renal, and inflammatory biology. CRISPR-based models provide powerful tools to establish causal roles of candidate genes in this pathway. EDITGENE offers comprehensive services to support such research, from knockout and point mutation to knock-in and overexpression models.
References
- 1. Qiao N et al.. 1999. Leukotriene A synthase activity of purified mouse skin arachidonate 8-lipoxygenase expressed in Escherichia coli.. Biochim Biophys Acta 1438(1):131-9 PMID: 10216287
- 2. Spector AA. 2009. Arachidonic acid cytochrome P450 epoxygenase pathway.. J Lipid Res 50 Suppl(Suppl):S52-6 PMID: 18952572
- 5. Li Z et al.. 2025. Irisin prevents liver injury during exhausting physical activity by suppressing ferroptosis via Nrf2/GPX4 signaling.. BMC Gastroenterol 25(1):516 PMID: 40646495
- 6. Vidal VN et al.. 2026. P2X receptors and lipids interact to modulate inflammation.. J Lipid Res 67(8):101084 PMID: 42320573
